Company: SWKH
Filing Date: 2025-04-29
Form Type: ANNLRPT
Source: 0001628280-25-020720
Chunk: 47

Company: SWK Holdings Corp
Filing Date: 2025-04-29
Form: ANNLRPT
Chunk 47
---
 3.4 |     | $      | -1.2 |
| Change in fair value of acquisition-related contingent consideration |     |                    | -4.9 |     |   | -6.3 |     | $      |  1.4 |
| Depreciation and amortization expense                                |     |                    |  1.4 |     |   |  2.6 |     | $      | -1.2 |
| General and administrative expense                                   |     |                    | 11.5 |     |   | 11.2 |     | $      |  0.3 |
| Other income, net                                                    |     |                    |  6.8 |     |   |    — |     | $      |  6.8 |
| Income tax expense (benefit)                                         |     |                    |  4.9 |     |   | -1.3 |     | $      |  6.2 |
| Net income                                                           |     |                    | 13.5 |     |   | 15.9 |     | $      | -2.4 |

#### Revenues
Revenues increased to $45.0 million for the year ended December 31, 2024 from $37.8 million for the year ended December 31, 2023. The $7.2 million increase in revenue for the year ended December 31, 2024 consisted of a $4.8 million increase in Finance Receivables segment revenue and a $2.4 million increase in Pharmaceutical Development segment revenue. The $4.8 million increase in Finance Receivables segment revenue was primarily due to a $8.2 million increase in interest and fees earned due to funding new and existing loans offset by $2.5 million decrease in interest, fees and royalties earned on finance receivables that were paid off during the period. The increase in the Pharmaceutical Development segment was primarily due to the strategic partner collaboration agreement.

#### Provision for Credit Losses
Our provision for credit losses is established through charges or credits to income in the form of the provision in order to bring our allowance for credit losses for loans and unfunded commitments to a level deemed appropriate by management. We recognized a net provision for credit losses of $12.8 million and $1.9 million for the years ended December 31, 2024 and 2023, respectively. Most of the change was related to a $8.1